TXLNG

Across TCGA pan-cancer cohorts, TXLNG mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TXLNG data layer compared with 25 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TXLNG mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated TXLNG expression acts as an unfavorable survival marker, although some lineages such as UCEC and GBM show a favorable association.

UCEC, CCRCC, and HNSC are the cancer types where TXLNG mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	III,IV	1.000	0.386	.002	28	view →
CCRCC	OS	Median	All	0.637	1.000	.003	17	view →
HNSC	DFS	Quartile	III,IV	0.638	0.867	.014	4	view →
GBM	DFS	Quartile	All	0.456	0.188	.030	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

TXLNG–UCEC (DFS)

Open the UCEC breakdown →